Meanwhile, both younger (median 60 vs. 68 years old) and diffuse histology (21.2% vs. 4.7%) GC patients showed more frequent CDH1 mutations in the TCGA cohort as well (p < 0.05). This evidence concerns the gene CDH1 and gastric cancer.